Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 RNAi for Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNAi for Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNAi for Therapeutic Overall Market Size
2.1 Global RNAi for Therapeutic Market Size: 2022 VS 2029
2.2 Global RNAi for Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNAi for Therapeutic Players in Global Market
3.2 Top Global RNAi for Therapeutic Companies Ranked by Revenue
3.3 Global RNAi for Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 RNAi for Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNAi for Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNAi for Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 RNAi for Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNAi for Therapeutic Market Size Markets, 2022 & 2029
4.1.2 siRNA
4.1.3 miRNA
4.1.4 shRNA
4.2 By Type - Global RNAi for Therapeutic Revenue & Forecasts
4.2.1 By Type - Global RNAi for Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global RNAi for Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global RNAi for Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNAi for Therapeutic Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Cardiovascular
5.1.4 HBV
5.1.5 Others
5.2 By Application - Global RNAi for Therapeutic Revenue & Forecasts
5.2.1 By Application - Global RNAi for Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global RNAi for Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global RNAi for Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global RNAi for Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global RNAi for Therapeutic Revenue & Forecasts
6.2.1 By Region - Global RNAi for Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global RNAi for Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global RNAi for Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America RNAi for Therapeutic Revenue, 2018-2029
6.3.2 US RNAi for Therapeutic Market Size, 2018-2029
6.3.3 Canada RNAi for Therapeutic Market Size, 2018-2029
6.3.4 Mexico RNAi for Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe RNAi for Therapeutic Revenue, 2018-2029
6.4.2 Germany RNAi for Therapeutic Market Size, 2018-2029
6.4.3 France RNAi for Therapeutic Market Size, 2018-2029
6.4.4 U.K. RNAi for Therapeutic Market Size, 2018-2029
6.4.5 Italy RNAi for Therapeutic Market Size, 2018-2029
6.4.6 Russia RNAi for Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries RNAi for Therapeutic Market Size, 2018-2029
6.4.8 Benelux RNAi for Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia RNAi for Therapeutic Revenue, 2018-2029
6.5.2 China RNAi for Therapeutic Market Size, 2018-2029
6.5.3 Japan RNAi for Therapeutic Market Size, 2018-2029
6.5.4 South Korea RNAi for Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia RNAi for Therapeutic Market Size, 2018-2029
6.5.6 India RNAi for Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America RNAi for Therapeutic Revenue, 2018-2029
6.6.2 Brazil RNAi for Therapeutic Market Size, 2018-2029
6.6.3 Argentina RNAi for Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNAi for Therapeutic Revenue, 2018-2029
6.7.2 Turkey RNAi for Therapeutic Market Size, 2018-2029
6.7.3 Israel RNAi for Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia RNAi for Therapeutic Market Size, 2018-2029
6.7.5 UAE RNAi for Therapeutic Market Size, 2018-2029
7 RNAi for Therapeutic Companies Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Company Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.2 Arbutus Biopharma (Tekmira)
7.2.1 Arbutus Biopharma (Tekmira) Company Summary
7.2.2 Arbutus Biopharma (Tekmira) Business Overview
7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Major Product Offerings
7.2.4 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Arbutus Biopharma (Tekmira) Key News & Latest Developments
7.3 Arrowhead
7.3.1 Arrowhead Company Summary
7.3.2 Arrowhead Business Overview
7.3.3 Arrowhead RNAi for Therapeutic Major Product Offerings
7.3.4 Arrowhead RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Arrowhead Key News & Latest Developments
7.4 Dicerna Pharmaceuticals
7.4.1 Dicerna Pharmaceuticals Company Summary
7.4.2 Dicerna Pharmaceuticals Business Overview
7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.4.4 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Dicerna Pharmaceuticals Key News & Latest Developments
7.5 Mirna Therapeutics
7.5.1 Mirna Therapeutics Company Summary
7.5.2 Mirna Therapeutics Business Overview
7.5.3 Mirna Therapeutics RNAi for Therapeutic Major Product Offerings
7.5.4 Mirna Therapeutics RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Mirna Therapeutics Key News & Latest Developments
7.6 Quark Pharmaceuticals
7.6.1 Quark Pharmaceuticals Company Summary
7.6.2 Quark Pharmaceuticals Business Overview
7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.6.4 Quark Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Quark Pharmaceuticals Key News & Latest Developments
7.7 RXi Pharmaceuticals
7.7.1 RXi Pharmaceuticals Company Summary
7.7.2 RXi Pharmaceuticals Business Overview
7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.7.4 RXi Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.7.5 RXi Pharmaceuticals Key News & Latest Developments
7.8 Silence Therapeutics
7.8.1 Silence Therapeutics Company Summary
7.8.2 Silence Therapeutics Business Overview
7.8.3 Silence Therapeutics RNAi for Therapeutic Major Product Offerings
7.8.4 Silence Therapeutics RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Silence Therapeutics Key News & Latest Developments
7.9 Benitec Biopharma
7.9.1 Benitec Biopharma Company Summary
7.9.2 Benitec Biopharma Business Overview
7.9.3 Benitec Biopharma RNAi for Therapeutic Major Product Offerings
7.9.4 Benitec Biopharma RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.9.5 Benitec Biopharma Key News & Latest Developments
7.10 miRagen Therapeutics
7.10.1 miRagen Therapeutics Company Summary
7.10.2 miRagen Therapeutics Business Overview
7.10.3 miRagen Therapeutics RNAi for Therapeutic Major Product Offerings
7.10.4 miRagen Therapeutics RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.10.5 miRagen Therapeutics Key News & Latest Developments
7.11 Sylentis
7.11.1 Sylentis Company Summary
7.11.2 Sylentis Business Overview
7.11.3 Sylentis RNAi for Therapeutic Major Product Offerings
7.11.4 Sylentis RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.11.5 Sylentis Key News & Latest Developments
7.12 Gradalis
7.12.1 Gradalis Company Summary
7.12.2 Gradalis Business Overview
7.12.3 Gradalis RNAi for Therapeutic Major Product Offerings
7.12.4 Gradalis RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.12.5 Gradalis Key News & Latest Developments
7.13 Sirnaomics
7.13.1 Sirnaomics Company Summary
7.13.2 Sirnaomics Business Overview
7.13.3 Sirnaomics RNAi for Therapeutic Major Product Offerings
7.13.4 Sirnaomics RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.13.5 Sirnaomics Key News & Latest Developments
7.14 Silenseed
7.14.1 Silenseed Company Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNAi for Therapeutic Major Product Offerings
7.14.4 Silenseed RNAi for Therapeutic Revenue in Global Market (2018-2023)
7.14.5 Silenseed Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer